Complex Post-traumatic Stress Disorder: What Symptomatological Specificities
NCT ID: NCT05070962
Last Updated: 2021-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2021-02-17
2023-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identification of the Clinical Specificities of Complex Posttraumatic Stress Disorder
NCT05592652
Treatment of Post Traumatic Stress Disorder in Patients With Other Mental Illnesses
NCT00053690
Post-Traumatic Stress Disorder (PTSD) Symptom Study
NCT00018798
Empathy in Post-traumatic Stress Disorder in Comparaison to a Control Population
NCT05617781
Effectiveness of Three Different Psychotherapies for Chronic Post-Traumatic Stress Disorder
NCT00739765
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clinical population
having experienced repeated and prolonged traumatic exposure
clinical population
or the general population, students of the University of Lille will be offered the opportunity to participate in a study through posters in the corridors of the faculties and announcements in the lecture halls.
General population
Student volunteers from the University of Lille
clinical population
or the general population, students of the University of Lille will be offered the opportunity to participate in a study through posters in the corridors of the faculties and announcements in the lecture halls.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
clinical population
or the general population, students of the University of Lille will be offered the opportunity to participate in a study through posters in the corridors of the faculties and announcements in the lecture halls.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 and 65 years old;
* Having experienced repeated and prolonged traumatic exposure;
* Able to understand and answer self-questionnaires;
* Having expressed their free and informed consent
* Affiliated with a social security scheme
For general population:
* Student volunteers from the University of Lille;
* Aged between 18 and 65 years old;
* Able to understand and answer self-questionnaires;
* Having expressed their free and informed consent.
Exclusion Criteria
* People with difficulties in answering the self-questionnaires (e.g. incomprehension of items, emotional difficulties);
* Persons under tutorship or curatorship;
* Persons deprived of their liberty.
For general population:
* People with difficulties in answering the self-questionnaires (e.g. incomprehension of items, emotional difficulties);
* Persons under tutorship or curatorship;
* Persons deprived of their liberty;
* Persons having a link of subordination with the investigative team.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Raincy Montfermeil Hospital Group
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marion SIMION
Role: PRINCIPAL_INVESTIGATOR
USAP CHI Robert Ballanger
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
USAP CHI Robert Ballanger Boulevard Robert Ballanger
Aulnay-sous-Bois, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GHT_ CHIRB -RIPH2_003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.